Testimony
-
U.S. House Committee on Energy and Commerce Subcommittee on Oversight and Investigations Testimony to Protecting America’s Seniors: Oversight of Private Sector Medicare Advantage Plans
June 28, 2022Erin Bliss, Assistant Inspector General, Office of Evaluation and Inspections, Office of Inspector General, U.S. Department of Health and Human Services
-
Committee on Health, Education, Labor and Pensions Testimony to Protecting U.S. Biomedical Research: Efforts to Prevent Undue Foreign Influence
April 22, 2021Gary L. Cantrell, Deputy Inspector General for Investigations, Office of Investigations, Office of Inspector General, U.S. Department of Health and Human Services
-
Committee on Oversight and Reform Testimony to Opening Statement for Member Briefing on the Administration’s Coronavirus Response
May 26, 2020Christi A. Grimm, Inspector General, Office of Inspector General, Office of Inspector General, U.S. Department of Health and Human Services
-
Committee on Appropriations Testimony to Budget/Oversight: Health and Human Services Office of Inspector General Testimony on: Oversight of the Food and Drug Administration
February 27, 2020Suzanne Murrin, Deputy Inspector General for Evaluation and Inspections, Office of Evaluation and Inspections, Office of Inspector General, U.S. Department of Health and Human Services
-
U.S. House Committee on Ways and Means Statement for the Record to Caring for Aging Americans
November 14, 2019 -
U.S. Senate Committee on Finance, Subcommittee on Health Care Testimony to Medicaid: Compliance with Eligibility Requirements
October 30, 2019Brian P. Ritchie, Assistant Inspector General for Audit Services, Office of Inspector General, U.S. Department of Health and Human Services
-
U.S. Senate Committee on Finance Testimony to OIG's Efforts to Address the Prescribing and Treatment Dimensions of the Opioid Crisis
October 24, 2019Gary L. Cantrell, Deputy Inspector General for Investigations, Office of Investigations, Office of Inspector General, U.S. Department of Health and Human Services
-
U.S. House Committee on Energy & Commerce Testimony to HHS-OIG Oversight of the Unaccompanied Alien Children Program
September 19, 2019Ann Maxwell, Deputy Inspector General for Evaluation and Inspections, Office of Evaluations and Inspections, Office of Inspector General, U.S. Department of Health and Human Services
-
U.S. House Committee on Appropriations Testimony to HHS-OIG Oversight of the Unaccompanied Alien Children Program
September 18, 2019Ann Maxwell, Deputy Inspector General for Evaluation and Inspections, Office of Evaluations and Inspections, Office of Inspector General, U.S. Department of Health and Human Services
-
United States Senate Committee on Finance Testimony to Promoting Elder Justice: A Call for Reform
July 23, 2019Megan H. Tinker, Senior Advisor for Legal Affairs, Office of Counsel to the Inspector General, Office of Inspector General, U.S. Department of Health and Human Services
-
U.S. House Committee on Oversight and Reform Testimony to HHS-OIG Oversight of the Unaccompanied Alien Children Program
July 12, 2019Ann Maxwell, Deputy Inspector General for Evaluation and Inspections, Office of Evaluations and Inspections, Office of Inspector General, U.S. Department of Health and Human Services
-
U.S. Senate Special Committee on Aging Testimony to The Complex Web of Prescription Drug Prices, Part III: Examining Agency Efforts to Further Competition and Increase Affordability
June 19, 2019Vicki L. Robinson, Senior Counselor for Policy, Office of Inspector General, U.S. Department of Health and Human Services
-
U.S. Senate Committee on Finance Testimony to Foreign Threats to Taxpayer-Funded Medical Research: Oversight Opportunities and Policy Solutions
June 5, 2019Leslie W. Hollie, Chief of Investigative Operations, Office of Investigations, Office of Inspector General, U.S. Department of Health and Human Services
-
U.S. House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations Testimony to Examining the Failures of the Trump Administration's Inhumane Family Separation Policy
February 7, 2019Ann Maxwell, Deputy Inspector General for Evaluation and Inspections, Office of Evaluations and Inspections, Office of Inspector General, U.S. Department of Health and Human Services
-
House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations Testimony to Examining Federal Efforts to Ensure Quality of Care and Resident Safety in Nursing Homes
September 6, 2018Ruth Ann Dorrill, Regional Inspector General, Office of Evaluation and Inspections, Office of Inspector General, U.S. Department of Health and Human Services
-
House Committee on Ways and Means Subcommittee on Oversight Testimony to Combating Fraud in Medicare: A Strategy for Success
July 17, 2018Gloria L. Jarmon, Deputy Inspector General for Audit Services, Office of Inspector General, U.S. Department of Health and Human Services
-
Senate Committee on Homeland Security and Governmental Affairs Testimony to Medicaid Fraud and Overpayments: Problems and Solutions
June 27, 2018Brian Ritchie, Assistant Inspector General, Office of Audit Services, Office of Inspector General, U.S. Department of Health and Human Services
-
Senate Committee on Finance Health Care Subcommittee Field Hearing Testimony to Examining Efforts to Prevent Opioid Overutilization and Misuse in Medicare and Medicaid
May 29, 2018Maureen Dixon, Special Agent in Charge, Philadelphia Regional Office, Office of Investigations, Office of Inspector General, U.S. Department of Health and Human Services
-
Senate Special Committee on Aging Testimony to Preventing and Treating Opioid Misuse Among Older Americans
May 23, 2018Gary L. Cantrell, Deputy Inspector General for Investigations, Office of Investigations, Office of Inspector General, U.S. Department of Health and Human Services
-
House Committee on Oversight and Government Reform, Subcommittee on Government Operations Subcommittee on Intergovernmental Affairs Testimony to Improper Payments in State-Administered Programs: Medicaid
April 12, 2018Megan H.Tinker, Senior Advisor for Legal Review, Office of Counsel to the Inspector General, Office of Inspector General, U.S. Department of Health and Human Services